Historical shareholding details of Raymond James & Associates holdings in CRISPR Therapeutics AG (CRSP)

Monthly changes of Raymond James & Associates shareholding in CRISPR Therapeutics AG over the previous months

Month Name Total no. shares held Percent Holding
Sep 30, 2024 Raymond James & Associates 31,949 0.04%
Jun 30, 2024 Raymond James & Associates 38,433 0.05%
Mar 31, 2024 Raymond James & Associates 34,954 0.04%
Dec 31, 2023 Raymond James & Associates 31,839 0.04%
Sep 30, 2023 Raymond James & Associates 28,608 0.04%
Jun 30, 2023 Raymond James & Associates 28,767 0.04%
Mar 31, 2023 Raymond James & Associates 57,132 0.07%

View all ownership details of CRISPR Therapeutics AG